Download file (13.3MB)
Download as zip (12.9MB)

コレクション

引用

説明:

This study investigated the evolving trends, current research hotspots, and future directions of radiotherapy combined with nanobiomaterials through a bibliometric analysis. Publications related to nanobiomaterials used in radiotherapy between 2004 and 2024 were retrieved from theWeb of Science Core Collection database and analyzed using VOSviewer, R, and CiteSpace. China emerged as the leading contributor, accounting for 1051 publications (50.41%), followed by the USA. Liu Zhuang is the most productive author in this field. American Chemical Society (ACS) Nano published the most influential articles and accumulated the highest number of citations. Advanced Targeted Therapies in Cancer: Drug Nanocarriers, the Future of Chemotherapy was the most cited, with 1255 citations. Citation bursts have revealed emerging research trends in targeted delivery, cellular studies, co-delivery strategies, immunogenic cell death, polymeric nanoparticles, tumor research, and drug delivery systems, indicating potential avenues for future research. Over the past two decades, nanomaterials for radiotherapy have gained substantial attention. Key areas of focus include enhancing the efficacy of radiotherapy, achieving targeted drug delivery, minimizing adverse effects, and integrating nanomaterials with other therapeutic modalities. Future investigations are expected to improve the precision of radiotherapy, augment radiation effects, and optimize the tumor microenvironment.

権利情報:

• Creative Commons BY Attribution 4.0 International
  

キーワード: radiotherapy, nanofibers, cancer

刊行年月日: 2025-08-06

出版者: MDPI AG

掲載誌:

• Nanomaterials (ISSN: 20794991) vol. 15 issue. 15 1205

研究助成金:

• Japan–China Sasakawa Medical Fellowship and JST SPRING JPMJSP2124

原稿種別: 出版者版 (Version of record)

MDR DOI:

公開URL: https://doi.org/10.3390/nano15151205

関連資料:

その他の識別子:

連絡先:

更新時刻: 2025-12-16 10:08:15 +0900

MDRでの公開時刻: 2025-12-19 14:11:43 +0900